Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Teva
McKesson
US Department of Justice
Johnson and Johnson
Citi
UBS
Express Scripts
Colorcon

Generated: June 23, 2018

DrugPatentWatch Database Preview

THEOPHYLLINE 0.08% AND DEXTROSE 5% IN PLASTIC CONTAINER Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Theophylline 0.08% And Dextrose 5% In Plastic Container, and what generic alternatives are available?

Theophylline 0.08% And Dextrose 5% In Plastic Container is a drug marketed by B Braun and is included in two NDAs.

The generic ingredient in THEOPHYLLINE 0.08% AND DEXTROSE 5% IN PLASTIC CONTAINER is theophylline. There are thirty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the theophylline profile page.
Summary for THEOPHYLLINE 0.08% AND DEXTROSE 5% IN PLASTIC CONTAINER
Drug patent expirations by year for THEOPHYLLINE 0.08% AND DEXTROSE 5% IN PLASTIC CONTAINER
Pharmacology for THEOPHYLLINE 0.08% AND DEXTROSE 5% IN PLASTIC CONTAINER
Ingredient-typeXanthines
Drug ClassMethylxanthine
Medical Subject Heading (MeSH) Categories for THEOPHYLLINE 0.08% AND DEXTROSE 5% IN PLASTIC CONTAINER

US Patents and Regulatory Information for THEOPHYLLINE 0.08% AND DEXTROSE 5% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun THEOPHYLLINE 0.08% AND DEXTROSE 5% IN PLASTIC CONTAINER theophylline INJECTABLE;INJECTION 019083-002 Nov 7, 1984 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
B Braun THEOPHYLLINE 0.08% AND DEXTROSE 5% IN PLASTIC CONTAINER theophylline INJECTABLE;INJECTION 019826-002 Aug 14, 1992 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Julphar
Fish and Richardson
Boehringer Ingelheim
McKinsey
UBS
AstraZeneca
Cantor Fitzgerald
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.